Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2
Closed -$83 5153
2025
Q4
$83 Sell
2
-24
-92% -$729 ﹤0.01% 4632
2025
Q3
$777 Buy
+26
New +$868 ﹤0.01% 4034
2025
Q2
Hold
0
4540
2018
Q4
Sell
-200
Closed -$15K 3839
2018
Q3
$15K Buy
+200
New +$13.8K ﹤0.01% 2626

IFP Advisors's SRDX Position: Q1 2026 in Review

IFP Advisors sold out of Surmodics (SRDX) in Q1 2026, closing a stake of 2 shares — an estimated $83 sold.

IFP Advisors first reported a position in SRDX in Q3 2018 and held it in 3 quarters. The position peaked at $15K in Q3 2018. 0 funds tracked by Wall St. Rank hold SRDX as of Q1 2026.

  • IFP Advisors reported no remaining Surmodics position as of Q1 2026 after selling out during the quarter.
  • IFP Advisors sold 2 Surmodics shares in Q1 2026, an estimated $83.
  • IFP Advisors first reported a position in Surmodics in Q3 2018 and held it in 3 quarters.
  • IFP Advisors's Surmodics position peaked at $15K in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Surmodics as of Q1 2026.

Based on IFP Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.